Endothelial cell biomarkers, including von Willebrand factor (vWF) antigen, vWF pro-peptide, and factor VIII, are significantly elevated in convalescent COVID-19, suggesting a persistent endotheliopathy [43]. This evidence concerns the gene VWF and COVID-19.